Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1942-2010

Inova Diagnostics BINDAZYME Human C1q binding Circulating Immune Complex EIA Kit, Part#: MK021

Inova Diagnostics, Inc. / initiated 2009-10-28 / Terminated / root cause: manufacturing process

Inova Diagnostics Incorporated began a recall of Inova Diagnostics BINDAZYME Human C1q binding Circulating Immune Complex EIA Kit, Part#: MK021 on . The reason FDA records is "The recall was initiated after the binding site notified Inova Diagnostics, inc. that the affected Bindazyme Human C1q binding Circulating Immune Complex EIA Kits may contain an ELISA plate labeled as "tissue...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1942-2010
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Inova Diagnostics, Inc.
Product
Inova Diagnostics BINDAZYME Human C1q binding Circulating Immune Complex EIA Kit, Part#: MK021
Product code
DAK Complement C1q, Antigen, Antiserum, Control
Reason for recall
The recall was initiated after the binding site notified Inova Diagnostics, inc. that the affected Bindazyme Human C1q binding Circulating Immune Complex EIA Kits may contain an ELISA plate labeled as "tissue Transglutaminase Coated Wells" instead of "C1q Coated Wells".
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Notification letters from INOVA Diagnostics Incorporated were mailed to each of the consignees via Certified mail on October 30, 2009. The notification letters inform the consignees of the reason for recall and provided instructions for final disposition of the recalled kits. In addition, a FAX back Attachment was attached to the recall notice for customers to respond to the recall.
Quantity in commerce
700 kits
Distribution
Worldwide distribution: USA, Germany, Italy, Belgium, Romania, Portugal, Argentina, Spain, Sweden, and India.
Product codes and lots
Lot numbers: 273005A, 273005B, 273005C, and 273005D